Unpredictable drops in income in a person’s early 20s through mid-30s have been associated with a nearly twofold increased risk of all-cause death or CVD events, including heart attack, stroke and heart failure.

The recent price cuts of the PCSK9 inhibitor alirocumab (Praluent) aren’t enough to make the cholesterol-lowering drug cost-effective compared to ezetimibe, according to an analysis published in the Jan. 1 issue of the Annals of Internal Medicine.

Chest imaging utilization in the emergency department (ED), including both x-rays and CT examinations, has increased in the last two decades, according to new findings published by the Journal of the American College of Radiology.

Verily, a subsidiary of Google parent company Alphabet, raised $1 billion in investment funding to support growth in strategic partnership investments, global business development opportunities and potential acquisitions, the company announced Jan. 3.

Denver-based Radiology Imaging Associates and San Antonio-based South Texas Radiology Group have partnered to create Covalent Radiology, a professional services company, and Covalent Healthcare Management, a full-service management services organization.

A Wall Street Journal investigation detailed how private health insurers have regularly overestimated the cost of covering prescription drug benefits for Medicare enrollees, allowing the insurers to keep $9.1 billion more from 2006 to 2015 than if their projections had been accurate.

The artificial intelligence (AI) in healthcare market is expected to reach $36.1 billion by 2025, according to a new report from the research firm MarketsandMarkets.

A new federal law took effect Jan. 1 requiring all hospitals to post their list prices online. But, as it turns out, what appears online may end up confusing price-conscious patients more than helping them.